Cindy Basinski, MD
Urogynecology and Reconstructive Pelvic Surgery · Newburgh, INNPI 1154345775
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $86,740 of the $132,433 with a category attached, or 65.5%. Hologic Sales And Service, LLC accounts for 86.4% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $77,447 and has fallen 72.3% since, to $21,452 in 2025. Among urogynecology and reconstructive pelvic surgery clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $913.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hologic Sales And Service, LLC$114K
- Bayer$9K
- Aegea Medical, Inc.$5K
- Caldera Medical, Inc$1K
- Cytyc Surgical Products, LLC$788
- Intuitive Surgical$575
- plus $2K from 16 others
Across 107 payments — averaging $3842.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$410K
- Aegea Medical, Inc.$1K
What the payments were for
- Consulting fees$86,74065%
- Speaking & faculty fees$37,62328%
- Travel & lodging$2,9602%
- Food & beverage$5,0374%
- Education$170%
- Gifts$560%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Hologic Sales And Service, LLC | 60 | $114,438 |
| Bayer | 14 | $8,834 |
| Aegea Medical, Inc. | 3 | $4,525 |
| Caldera Medical, Inc | 14 | $1,453 |
| Cytyc Surgical Products, LLC | 1 | $788 |
| Intuitive Surgical | 1 | $575 |
| Axonics, Inc. | 19 | $544 |
| Coloplast | 6 | $260 |
| Channel Medsystems, Inc. | 1 | $200 |
| Myriad Women's Health, Inc. | 1 | $196 |
| AbbVie | 5 | $167 |
| Gynesonics, Inc. | 3 | $141 |
| Boston Scientific | 5 | $99 |
| Pfizer | 3 | $47 |
| Laborie Medical Technologies Corp. | 1 | $32 |
| Valencia Technologies Corporation | 1 | $29 |
| Avion Pharmaceuticals | 2 | $22 |
| Johnson & Johnson | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Novo Nordisk | 1 | $15 |
| Nevro Corp. | 1 | $15 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NovaSure$111,275
- Myosure$45,813
- Xofigo$4,550
- MARA Water Vapor Ablation System$4,365
- Non-Covered$3,584
- NONE$1,050
- Desara$1,042
- Essure$700
- Da Vinci Surgical System$575
- Axonics$258
- CERENE CRYOTHERAPY DEVICE$200
- myRisk$196
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$194
- ACESSA PROVU SYSTEM$194
How this compares
$132,433 in reported general payments places this provider in the 95th percentile of 21 urogynecology and reconstructive pelvic surgery providers in Indiana.
See all urogynecology and reconstructive pelvic surgery providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 55 | $35,761 |
| GemtesaVibegron | 16 | $8,487 |
| Oxybutynin Chloride ErOxybutynin Chloride | 274 | $5,680 |
| Estradiol | 129 | $4,413 |
| Tolterodine Tartrate ErTolterodine Tartrate | 61 | $3,994 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 138 | $2,761 |
| YuvafemEstradiol | 13 | $1,723 |
| Solifenacin Succinate | 33 | $825 |
| Oxybutynin Chloride | 18 | $235 |
| Cephalexin | 31 | $145 |
| Ciprofloxacin Hcl | 22 | $82 |
| Fluconazole | 27 | $58 |
| Alendronate Sodium | 12 | $53 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $42 |
| Levofloxacin | 15 | $10 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $20 | $8,48716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 21 urogynecology and reconstructive pelvic surgery providers in Indiana.
Other urogynecology and reconstructive pelvic surgery in Newburgh
- Preston EdgeNewburgh$5K
- Kathryn CopelandCarmel$26K
- Jeffrey BlakeNoblesville$15K
- Ted RothSouth Bend$14K
- Krystine GulbrandDanville$13K
- Hussein WardaGreenwood$10K
- Amanda LaporteIndianapolis$9K
- Martina MutoneFishers$7K
- Scott BoydFort Wayne$7K
- Sara Diaz ValentinRichmond$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.